|
|
Volumn 94, Issue 7, 2002, Pages 2033-2039
|
|
Frequency and type of serious infections in fludarabine-refractory B-cell chronic lymphocytic leukemia and small lymphocytic lymphoma: Implications for clinical trials in this patient population
|
|
Author keywords
Chronic lymphocytic leukemia; Fludarabine; Infection; Refractory; Retrospective; Small lymphocytic lymphoma
|
|
Indexed keywords
ANTIBIOTIC AGENT;
ANTILEUKEMIC AGENT;
FLUDARABINE;
ADULT;
AGED;
ANTIBIOTIC PROPHYLAXIS;
ANTIBIOTIC THERAPY;
ARTICLE;
B CELL LEUKEMIA;
BACTERIAL INFECTION;
CANCER RESISTANCE;
CANCER SURVIVAL;
CHRONIC LYMPHATIC LEUKEMIA;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DISEASE COURSE;
DISEASE SEVERITY;
FEMALE;
HIGH RISK PATIENT;
HOSPITAL ADMISSION;
HUMAN;
HYPOGAMMAGLOBULINEMIA;
INFECTION RATE;
LYMPHOCYTOMA;
MALE;
MYCOSIS;
OPPORTUNISTIC INFECTION;
PNEUMOCYSTIS PNEUMONIA;
PRIORITY JOURNAL;
RESPIRATORY TRACT INFECTION;
RETROSPECTIVE STUDY;
SEPTICEMIA;
SOFT TISSUE INFECTION;
URINARY TRACT INFECTION;
VIRUS INFECTION;
|
|
EID: 0036534380
PISSN: 0008543X
EISSN: None
Source Type: Journal
DOI: 10.1002/cncr.0680 Document Type: Article |
|
Times cited : (131)
|
|
References (31)
|
